11. Psychiatric Disorders: A Complete Guide to Depression, Anxiety, and Psychosis

PSYCHIATRIC DISORDERS AND PHARMACOTHERAPY

Welcome, future pharmacists and healthcare professionals!

As a pharmacotherapeutics educator with years of experience teaching psychiatry and mental health, I have observed that many patients suffer in silence because of the stigma associated with mental illness. Psychiatric disorders are conditions that affect a person’s emotions, thoughts, and behavior, making daily life difficult. These mental health issues are very common, yet many people hesitate to talk about them or seek help. Depression, anxiety, and psychosis are among the most prevalent psychiatric disorders worldwide, affecting millions of people across all age groups.

In this comprehensive guide, I will take you through three major psychiatric disorders: Depression, Anxiety, and Psychosis. We will explore their types, causes, symptoms, diagnostic approaches, and evidence-based pharmacotherapy and non-pharmacological management strategies. By the end of this article, you will have the knowledge and confidence to counsel patients effectively, recognize red flags, and contribute to better mental health outcomes. Let us begin.

PART 1: DEPRESSION

What is Depression?

Depression is a common mental health condition characterized by persistent sadness, loss of interest in daily activities, feelings of guilt, low energy, and difficulty concentrating. It is one of the leading causes of disability worldwide, affecting more than 264 million people globally. Depression is not simply a state of feeling sad or down—it is a serious medical condition that can significantly impact a person’s quality of life, relationships, and physical health.

The pathophysiology of depression involves complex interactions between genetic, biological, environmental, and psychological factors. Neurotransmitter imbalances, particularly involving serotonin, norepinephrine, and dopamine, play a central role in the development of depressive symptoms. Stress, trauma, and hormonal changes can also contribute to the onset of depression.

Types of Depression

Depression can present in various forms, each with distinct characteristics:

• Major Depressive Disorder (MDD): Characterized by persistent depressive episodes lasting at least two weeks, with significant impairment in daily functioning.
• Persistent Depressive Disorder (PDD): A chronic form of depression lasting for at least two years, with symptoms that may be less severe but more enduring.
• Bipolar Disorder: Involves alternating episodes of depression and mania or hypomania.
• Postpartum Depression: Depression that occurs after childbirth, affecting up to 15% of new mothers.
• Seasonal Affective Disorder (SAD): Depression that occurs during specific seasons, typically winter, due to reduced sunlight exposure.
• Premenstrual Dysphoric Disorder (PMDD): A severe form of premenstrual syndrome with prominent depressive symptoms.

Causes of Depression

Depression is caused by a combination of factors, including:

• Genetic factors: A family history of depression increases the risk of developing the condition.
• Neurochemical imbalance: Dysregulation of neurotransmitters such as serotonin, norepinephrine, and dopamine.
• Stress and trauma: Major life events, chronic stress, childhood trauma, and abuse can trigger depression.
• Hormonal changes: Pregnancy, postpartum, menopause, and thyroid disorders can contribute to depressive symptoms.
• Chronic illnesses: Conditions such as diabetes, cardiovascular disease, and chronic pain are associated with higher rates of depression.

Symptoms of Depression

The symptoms of depression can vary in severity and duration. Common symptoms include:

• Persistent sadness, emptiness, or hopelessness
• Loss of interest or pleasure in previously enjoyed activities
• Significant fatigue or loss of energy
• Sleep disturbances: Insomnia or hypersomnia
• Appetite changes: Significant weight loss or gain
• Feelings of guilt, worthlessness, or helplessness
• Poor concentration and difficulty making decisions
• Psychomotor agitation or retardation
• Suicidal thoughts or ideation

Management of Depression

Non-Pharmacological Management

Non-pharmacological approaches are essential components of depression management:

• Cognitive Behavioral Therapy (CBT): A structured, evidence-based psychotherapy that helps patients identify and change negative thought patterns and behaviors.
• Interpersonal Therapy (IPT): Focuses on improving interpersonal relationships and social functioning.
• Regular exercise: Physical activity has been shown to be as effective as antidepressants for mild to moderate depression.
• Lifestyle modifications: Healthy diet, adequate sleep, and stress reduction techniques.
• Electroconvulsive Therapy (ECT): Used in severe, treatment-resistant depression or when rapid response is needed.
• Psychological support: Family support, peer support groups, and counseling.

Pharmacological Management

Several classes of antidepressants are available for the treatment of depression:

• Selective Serotonin Reuptake Inhibitors (SSRIs): First-line treatment for depression. Examples include fluoxetine, sertraline, escitalopram, and paroxetine.
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Effective for both depression and anxiety. Examples include venlafaxine and duloxetine.
• Tricyclic Antidepressants (TCAs): Used for treatment-resistant depression. Examples include amitriptyline and imipramine.
• Monoamine Oxidase Inhibitors (MAOIs): Used in atypical depression. Examples include phenelzine and tranylcypromine.
• Atypical Antidepressants: Examples include bupropion and mirtazapine, which have different mechanisms of action.

Best results are achieved by combining medication with psychotherapy. Patients should be monitored for side effects and response to treatment.

PART 2: ANXIETY DISORDERS

What is Anxiety?

Anxiety is a normal response to stress or perceived danger. However, when anxiety becomes excessive, persistent, and interferes with daily functioning, it is classified as an anxiety disorder. Anxiety disorders are the most common mental health conditions, affecting approximately 1 in 4 people at some point in their lives.

The pathophysiology of anxiety involves hyperactivity of the amygdala, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, and imbalances in neurotransmitters such as GABA, serotonin, and norepinephrine.

Types of Anxiety Disorders

Anxiety disorders encompass a range of conditions:

• Generalized Anxiety Disorder (GAD): Excessive, uncontrollable worry about various aspects of daily life.
• Panic Disorder: Recurrent, unexpected panic attacks with physical symptoms such as palpitations, sweating, and breathlessness.
• Social Anxiety Disorder: Intense fear of social situations and being judged negatively by others.
• Phobias: Irrational, intense fear of specific objects or situations (e.g., agoraphobia, claustrophobia).
• Obsessive-Compulsive Disorder (OCD): Recurrent, intrusive thoughts (obsessions) and repetitive behaviors (compulsions).
• Post-Traumatic Stress Disorder (PTSD): Anxiety triggered by exposure to a traumatic event.

Symptoms of Anxiety

Anxiety symptoms can be categorized into three domains:

• Physical symptoms: Rapid heartbeat, palpitations, sweating, trembling, shortness of breath, chest tightness, and dizziness.
• Mental symptoms: Excessive worry, fear of losing control, racing thoughts, difficulty concentrating, and irritability.
• Behavioral symptoms: Avoidance of feared situations, restlessness, and compulsive behaviors.

Management of Anxiety Disorders

Non-Pharmacological Management

Non-pharmacological interventions are essential for anxiety management:

• Cognitive Behavioral Therapy (CBT): The gold standard psychotherapy for anxiety disorders.
• Exposure Therapy: Gradually exposing the patient to feared situations or objects in a controlled manner.
• Relaxation Techniques: Deep breathing exercises, progressive muscle relaxation, and mindfulness meditation.
• Regular Exercise: Physical activity reduces anxiety symptoms and improves overall well-being.
• Lifestyle Modifications: Adequate sleep, healthy diet, and reducing caffeine and alcohol intake.

Pharmacological Management

Several classes of medications are used to treat anxiety disorders:

• Benzodiazepines: Short-term use for acute anxiety (e.g., alprazolam, lorazepam, diazepam). Long-term use is discouraged due to dependence risk.
• SSRIs and SNRIs: First-line long-term treatment for anxiety disorders (e.g., sertraline, paroxetine, venlafaxine).
• Beta-blockers: Used for performance anxiety and physical symptoms (e.g., propranolol).
• Buspirone: A non-benzodiazepine anxiolytic for GAD.
• Tricyclic Antidepressants (TCAs): Used for anxiety when other treatments are ineffective.

PART 3: PSYCHOSIS

What is Psychosis?

Psychosis is a severe mental condition in which a person loses contact with reality. It is characterized by hallucinations, delusions, and disorganized thinking. Psychosis can occur as a symptom of various psychiatric disorders, most notably schizophrenia, but can also be caused by substance use, medical conditions, or severe stress.

The pathophysiology of psychosis involves dysregulation of the dopamine system in the brain, particularly in the mesolimbic and mesocortical pathways. Other neurotransmitter systems, including glutamate and serotonin, are also implicated.

Symptoms of Psychosis

The core symptoms of psychosis include:

• Hallucinations: Sensory perceptions without external stimuli (e.g., hearing voices, seeing things that are not there).
• Delusions: Fixed, false beliefs that are not based on reality (e.g., paranoid delusions, grandiose delusions).
• Disorganized thinking and speech: Incoherent speech, jumping between unrelated topics, and loose associations.
• Confusion and disorientation: Difficulty understanding reality and distinguishing what is real from what is not.
• Negative symptoms: Reduced emotional expression, lack of motivation, and social withdrawal.

Causes of Psychosis

Psychosis can be caused by various factors:

• Psychiatric disorders: Schizophrenia, schizoaffective disorder, bipolar disorder (with psychotic features).
• Substance use: Cannabis, amphetamines, cocaine, hallucinogens, and alcohol withdrawal.
• Medical conditions: Neurological disorders, brain tumors, infections, and endocrine disorders.
• Traumatic events: Severe stress and trauma can trigger psychotic episodes.
• Genetic factors: Family history of psychosis or schizophrenia increases risk.

Management of Psychosis

Non-Pharmacological Management

Non-pharmacological approaches are essential for comprehensive psychosis management:

• Supportive care and stabilization: Creating a safe and structured environment.
• Psychotherapy: Cognitive behavioral therapy for psychosis (CBTp) helps patients cope with symptoms.
• Family support and psychoeducation: Educating families about psychosis and treatment adherence.
• Social skills training: Helping patients improve interpersonal and daily living skills.
• Routine stabilization: Maintaining regular sleep, diet, and daily activities.

Pharmacological Management

Antipsychotic medications are the mainstay of psychosis treatment:

• Typical (First-Generation) Antipsychotics: Effective for positive symptoms but have significant extrapyramidal side effects. Examples include haloperidol and chlorpromazine.
• Atypical (Second-Generation) Antipsychotics: First-line treatment with lower extrapyramidal side effects. Examples include risperidone, olanzapine, quetiapine, aripiprazole, and clozapine.
• Third-Generation Antipsychotics: Include cariprazine and brexpiprazole, with unique receptor profiles.

Psychosis requires long-term treatment and regular monitoring. Patients should be educated about the importance of adherence to medication and follow-up appointments to prevent relapse.

COMPARISON TABLE: DEPRESSION VS ANXIETY VS PSYCHOSIS

Feature	Depression	Anxiety	Psychosis
Primary symptom	Persistent sadness, low mood	Excessive worry and fear	Hallucinations, delusions
Key features	Loss of interest, fatigue, guilt	Physical symptoms, avoidance	Loss of reality contact
Neurotransmitter involvement	Serotonin, norepinephrine	GABA, serotonin, norepinephrine	Dopamine, glutamate
First-line pharmacotherapy	SSRIs, SNRIs	SSRIs, SNRIs, benzodiazepines	Atypical antipsychotics
Non-pharmacological	CBT, exercise, ECT	CBT, exposure therapy, relaxation	CBTp, supportive care
Need for monitoring	Regular for side effects	Regular for dependence risk	Lifelong monitoring

A TEACHER’S CLINICAL INSIGHTS

Over my years of teaching psychopharmacology and psychiatric disorders, I have developed a few key insights that I always share with my students:

• Depression is not a sign of weakness—it is a medical condition that requires treatment. Always validate your patients’ feelings and avoid stigmatizing language.
• Anxiety disorders are highly treatable, but many patients do not seek help because they consider their symptoms as “normal stress.” Educate patients about when to seek professional help.
• Psychosis requires urgent evaluation and treatment. Delays in treatment can lead to poor outcomes and increased relapse rates.
• Psychotherapy and pharmacotherapy are complementary, not alternatives. Combining both approaches yields the best outcomes for most patients.
• Suicidal ideation is a medical emergency. Always ask patients directly about suicidal thoughts and ensure immediate referral to a mental health professional.

FREQUENTLY ASKED QUESTIONS (FAQs)

1. What is depression?

Depression is a mental disorder characterized by persistent sadness, loss of interest, fatigue, and difficulty concentrating. It is one of the leading causes of disability worldwide.

2. What is an anxiety disorder?

Anxiety disorder is a condition of excessive fear, worry, and nervousness that interferes with daily life. It includes conditions such as GAD, panic disorder, social anxiety disorder, and phobias.

3. What is psychosis?

Psychosis is a severe mental condition where a person loses contact with reality, experiencing hallucinations, delusions, and disorganized thinking. It requires urgent evaluation and treatment.

4. What are the first-line antidepressants?

Selective Serotonin Reuptake Inhibitors (SSRIs) such as fluoxetine, sertraline, and escitalopram are the first-line antidepressants for depression and anxiety disorders.

5. Can anxiety be treated without medication?

Yes, anxiety can be managed effectively with psychotherapy such as Cognitive Behavioral Therapy (CBT), lifestyle modifications, and relaxation techniques. Medication may be needed for moderate to severe cases.

6. What is the difference between typical and atypical antipsychotics?

Typical antipsychotics primarily block dopamine receptors and are effective for positive symptoms but have significant side effects. Atypical antipsychotics have a broader receptor profile with lower extrapyramidal side effects and are the first-line treatment for psychosis.

7. Can psychiatric disorders be cured?

Most psychiatric disorders can be effectively managed but not cured. With proper treatment and support, many patients achieve significant improvement and lead fulfilling lives.

SUMMARY

Psychiatric disorders like depression, anxiety, and psychosis require early diagnosis and a combination of pharmacological and non-pharmacological management for effective treatment. Depression is characterized by persistent sadness and loss of interest and is managed with SSRIs, SNRIs, and psychotherapy. Anxiety disorders involve excessive fear and worry and are treated with CBT, SSRIs, SNRIs, and short-term benzodiazepines. Psychosis involves loss of contact with reality and requires antipsychotic medications, particularly atypical antipsychotics, along with supportive care and psychotherapy.

As healthcare professionals, we have a responsibility to reduce the stigma associated with mental illness, educate patients about their conditions, and provide compassionate, evidence-based care.

As I always tell my students: “Mental health is just as important as physical health. Treat every patient with dignity, empathy, and respect.”

REFERENCES AND FURTHER READING

• Kasper, D. L., Fauci, A. S., Hauser, S. L., et al. (2020). Harrison’s Principles of Internal Medicine (21st ed.). McGraw-Hill.
• Stahl, S. M. (2021). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press.
• American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., Text Revision). APA Publishing.
• National Institute of Mental Health (NIMH). (2022). Mental Health Resources. Retrieved from https://www.nimh.nih.gov
• World Health Organization (WHO). (2022). Mental Health Resources. Retrieved from https://www.who.int

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for diagnosis and treatment.